Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors

1. Pryce, G.
2. Cabranes, A.
3. Fernández-Ruiz, J.
4. Bisogno, T.
5. Di Marzo, V.
6. Long, J.Z.
7. Cravatt, B.F.
8. Giovannoni, G.
9. Baker, D.